Literature DB >> 33989437

Successful treatment of thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26.COV2.S vaccination.

Gemlyn George1, Kenneth D Friedman2,3, Brian R Curtis2, Stuart E Lind4.   

Abstract

Entities:  

Year:  2021        PMID： 33989437     DOI： 10.1002/ajh.26237

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  10 in total

1.  Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.

Authors:  Adam J Kanack; Antonios Bayas; Gemlyn George; Mouhamed Yazan Abou-Ismail; Bandana Singh; Mindy C Kohlhagen; Noah P Splinter; Monika Christ; Markus Naumann; Karen A Moser; Kristi J Smock; Alison Grazioli; Renren Wen; Demin Wang; David L Murray; Anand Padmanabhan
Journal:  Blood       Date:  2022-07-07       Impact factor: 25.476

Review 2.  Advances in the design and development of SARS-CoV-2 vaccines.

Authors:  Xue-Liang Peng; Ji-Si-Yu Cheng; Hai-Lun Gong; Meng-Di Yuan; Xiao-Hong Zhao; Zibiao Li; Dai-Xu Wei
Journal:  Mil Med Res       Date:  2021-12-16

3.  Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.

Authors:  B Singh; A Kanack; A Bayas; G George; M Y Abou-Ismail; M Kohlhagen; M Christ; M Naumann; K Moser; K Smock; A Grazioli; D Murray; A Padmanabhan
Journal:  medRxiv       Date:  2021-09-24

4.  Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review.

Authors:  Usama Waqar; Shaheer Ahmed; Syed M H Ali Gardezi; Muhammad Sarmad Tahir; Zain Ul Abidin; Ali Hussain; Natasha Ali; Syed Faisal Mahmood
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 5.  Cerebral Venous Sinus Thrombosis following COVID-19 Vaccination: Analysis of 552 Worldwide Cases.

Authors:  Cesare de Gregorio; Luigi Colarusso; Giuseppe Calcaterra; Pier Paolo Bassareo; Antonio Ieni; Anna Teresa Mazzeo; Giuseppe Ferrazzo; Alberto Noto; Ioanna Koniari; Jawahar L Mehta; Nicholas G Kounis
Journal:  Vaccines (Basel)       Date:  2022-02-03

6.  Refined Capsid Structure of Human Adenovirus D26 at 3.4 Å Resolution.

Authors:  Vijay S Reddy; Xiaodi Yu; Michael A Barry
Journal:  Viruses       Date:  2022-02-17       Impact factor: 5.048

7.  Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.

Authors:  Adam J Kanack; Bandana Singh; Gemlyn George; Krishna Gundabolu; Scott A Koepsell; Mouhamed Yazan Abou-Ismail; Karen A Moser; Kristi J Smock; David Green; Ajay Major; Clarence W Chan; Geoffrey D Wool; Mark Reding; Aneel A Ashrani; Antonios Bayas; Diane E Grill; Anand Padmanabhan
Journal:  Am J Hematol       Date:  2022-02-21       Impact factor: 13.265

8.  Comparison of replicating and nonreplicating vaccines against SARS-CoV-2.

Authors:  Haley E Mudrick; Shane Massey; Erin B McGlinch; Brian J Parrett; Jack R Hemsath; Mary E Barry; Jeffrey D Rubin; Chisom Uzendu; Michael J Hansen; Courtney L Erskine; Virginia P Van Keulen; Aleksandra Drelich; Joseph A Panos; Madiha Fida; Gina A Suh; Tobias Peikert; Matthew S Block; Chien-Te Kent Tseng; Gloria R Olivier; Michael A Barry
Journal:  Sci Adv       Date:  2022-08-24       Impact factor: 14.957

Review 9.  A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination.

Authors:  Lii Jye Tan; Cai Ping Koh; Shau Kong Lai; Woon Cheng Poh; Mohammad Shafie Othman; Huzlinda Hussin
Journal:  Forensic Sci Int       Date:  2022-09-20       Impact factor: 2.676

Review 10.  COVID-19: Vaccine-induced immune thrombotic thrombocytopenia.

Authors:  Fazal-I-Akbar Danish; Ahmad Ehsan Rabani; Fazal-E-Rabi Subhani; Saeeda Yasmin; Salman Shafi Koul
Journal:  Eur J Haematol       Date:  2022-08-28       Impact factor: 3.674
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.